is there a benefit to rituximab maintenance after first-line bendamustine-rituximab for mcl?
Published 13 hours ago • 40 plays • Length 3:10Download video MP4
Download video MP3
Similar videos
-
1:01
advancements in cml: improving treatment-free remission and novel agents
-
2:41
advancements in aml: an update from ash 2023
-
1:30
advancements in prognostication tools in mpns in recent years
-
2:41
an overview of the latest advances in hematology
-
1:46:07
hematology lecture
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
9:25
mgus diagnosis: a step-by-step approach
-
1:04
long-term survival outcomes in pts with mf treated with momelotinib vs danazol in the momentum trial
-
3:02
the role of asparaginase in the treatment of all
-
1:00
the role of non-covalent btk inhibitors in the treatment of non-hodgkin lymphoma
-
1:49
genomic advancements in non-malignant hematology
-
1:07
key advancements in the treatment of bpdcn from ebmt 2024
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
1:47
shared treatment decision-making
-
1:13
the unmet needs and future of cmml treatment
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:09
advances in the management of fit adults with aml
-
2:03
the mcl complete project: nationwide data collection
-
4:14
key challenges in hemophilia management and diagnosis in resource-constrained countries
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
2:53
considering the sequencing of covalent and non-covalent btk inhibitors in cll